Archive
BioMed Alliance and EIT Health sign Memorandum of Understanding
- Details
The BioMed Alliance is very happy to announce the signing of a Memorandum of Understanding (MoU) with EIT Health to facilitate cooperation related to education and the promotion of innovation.
EIT Health is one of the largest health innovation networks in Europe, representing all types of health stakeholders from academia to industry, and research and health care delivery to start-ups. It is part of the European Institute of Innovation Technology (a body of the European Union created in 2008 to strengthen innovation in Europe and part of Horizon 2020). With approximately 150 partners it aims at delivering innovative solutions to enhance the health of European citizens.
The signing of this MoU represents a move towards closer collaboration between the healthcare innovation sector and medical societies across Europe and will greatly facilitate cooperation and allow us to work together on issues of common interest.
For more information, the press release is available here.
ERJ Article: Moving forward from drug-centred to patient-centred clinical research
- Details
An updated version of the White Paper on academic clinical research initiated by EORTC and written in cooperation with the BioMed Alliance was published in the European Respiratory Journal in February 2019. This article includes the patient perspective and describes specific policy angles to tackle related issues. The article can be found here.
Moving forward from drug-centered to patient-centered clinical research
- Details
Maximizing the potential of precision medicine for patients and healthcare services is a major societal challenge. It requires a holistic approach to the development of therapeutic strategies and a re-thinking of the entire process, including the role of the respective stakeholders and the way they interact, from the early steps of drug development to access in real life.
The BioMed Alliance calls on the European Institutions to increase the total Horizon Europe budget to at least €120-125 billion, and to dedicate 25-30% of the Horizon Europe budget to biomedical and health-related research
- Details
Structural elements of European biomedical research funding should be developed with a priority over funding of individual thematic areas and topics.
The Scientific Panel for Health* finalized a consensus document that proposes a way forward through the development of a European Council for Health Research
- Details
The European Council for Health Research will provide a science-led vision and long-term strategy for health research, which involves citizens, patients, health professionals and researchers
More info here
*The Scientific Panel for Health (SPH) is a science-led expert group based on the provisions of the Horizon 2020 Specific Programme that has been tasked with helping to achieve better health and wellbeing for all.
The BioMed Alliance calls for more robust EU support for health research, through increased funding under FP9 and the development of a long-term vision and strategy involving the creation of a European Council for Health Research
- Details
The BioMed Alliance welcomes the first review of the Directive on the protection of animals used for scientific purposes (Directive 2010/63/EU)
- Details
The BioMed Alliance agrees with the European Commission that efforts now need to be more strongly directed towards ensuring the Directive’s proper implementation and enforcement in all EU Member States.
BioMed Alliance and FEAM have joined forces
- Details
BioMed Alliance and FEAM have joined forces to highlight the need to provide a more robust environment for academic clinical and health research in Europe in view of the forthcoming EU Framework Programme for Research and Innovation (FP9).
BioMed Alliance recommendations for the future of EU research and innovation
- Details
To provide more robust feedback on Horizon 2020 and help shape the future of European research and innovation, the Alliance for Biomedical Research in Europe (BioMed Alliance) surveyed its membership.
More info here:
BioMed Alliance recommendations for the future of EU research and innovation
BioMed Alliance response to the European Medicines Agency’s public consultation: Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products
- Details
BioMed Alliance response to the European Medicines Agency’s public consultation: Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products
The European Medicines Agency has released for public consultation a draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.
BioMed Alliance Position Statement in support of the EU Directive on Animal Research (2010/63/EU)
- Details
European researchers call for the intensification of efforts to develop and adopt alternative approaches, while ensuring a viable context for the pursuit of animal experimentation, when unavoidable.
Input on the Scientific Panel for Health Vision Paper
- Details
More info here:
BioMed Alliance statement on the Scientific Panel for Health Paper Vision
BioMed Alliance provided recommendations on the development of the work programme 2018-2020 defining the calls and action that will implement the Framework Programme.
- Details
BioMed Alliance welcomes European Commission reply to "Stop Vivisection" European Citizens' Initiative.
- Details
Maintain the excellence of Europe in science by preserving the use of animals in research
- Details
Statement by the Alliance for Biomedical Research in Europe.
Preserving health and scientific research in Europe
- Details
Statement by the Alliance for Biomedical Research on EU Data Protection Regulation (March 2015)
The European Fund for Strategic Investments is threatening research
- Details
Statement by the Alliance for Biomedical Research in Europe.
The Alliance for Biomedical Research in Europe endorses the League of European Research Universities’
- Details
The Alliance for Biomedical Research in Europe endorses the League of European Research Universities’ position and the Wellcome Trust’s Statement in support of the EU Directive on the protection of animals used for scientific purposes.
Statement by the Alliance for Biomedical Research in Europe on the European Commission’s proposal for a European Data Protection Regulation (February 2013)
- Details
More info here: